Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Research Report 2024

Report ID: 1983855 | Published Date: Jan 2025 | No. of Page: 87 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Overview
    1.1 Product Overview and Scope of Oral Solid Dosage Forms (OSDF) and Pharma Excipients
    1.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Segment by Type
        1.2.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size Growth Rate Analysis by Type 2022 VS 2028
        1.2.2 Glycerin
        1.2.3 Propylene Glycol
        1.2.4 Sorbitol
        1.2.5 Mannitol
        1.2.6 Others
    1.3 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Segment by Application
        1.3.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption Comparison by Application: 2022 VS 2028
        1.3.2 Industrial Application
        1.3.3 Non-industrial Application
    1.4 Global Market Growth Prospects
        1.4.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Estimates and Forecasts (2017-2028)
        1.4.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity Estimates and Forecasts (2017-2028)
        1.4.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Estimates and Forecasts (2017-2028)
    1.5 Global Market Size by Region
        1.5.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size Estimates and Forecasts by Region: 2017 VS 2021 VS 2028
        1.5.2 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Estimates and Forecasts (2017-2028)
        1.5.3 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Estimates and Forecasts (2017-2028)
        1.5.4 China Oral Solid Dosage Forms (OSDF) and Pharma Excipients Estimates and Forecasts (2017-2028)
        1.5.5 Japan Oral Solid Dosage Forms (OSDF) and Pharma Excipients Estimates and Forecasts (2017-2028)
2 Market Competition by Manufacturers
    2.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity Market Share by Manufacturers (2017-2022)
    2.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Manufacturers (2017-2022)
    2.3 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.4 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Average Price by Manufacturers (2017-2022)
    2.5 Manufacturers Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Sites, Area Served, Product Types
    2.6 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Competitive Situation and Trends
        2.6.1 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Concentration Rate
        2.6.2 Global 5 and 10 Largest Oral Solid Dosage Forms (OSDF) and Pharma Excipients Players Market Share by Revenue
        2.6.3 Mergers & Acquisitions, Expansion
3 Production Capacity by Region
    3.1 Global Production Capacity of Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Share by Region (2017-2022)
    3.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Region (2017-2022)
    3.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity, Revenue, Price and Gross Margin (2017-2022)
    3.4 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production
        3.4.1 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Growth Rate (2017-2022)
        3.4.2 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity, Revenue, Price and Gross Margin (2017-2022)
    3.5 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production
        3.5.1 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Growth Rate (2017-2022)
        3.5.2 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity, Revenue, Price and Gross Margin (2017-2022)
    3.6 China Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production
        3.6.1 China Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Growth Rate (2017-2022)
        3.6.2 China Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity, Revenue, Price and Gross Margin (2017-2022)
    3.7 Japan Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production
        3.7.1 Japan Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Growth Rate (2017-2022)
        3.7.2 Japan Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity, Revenue, Price and Gross Margin (2017-2022)
4 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption by Region
    4.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption by Region
        4.1.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption by Region
        4.1.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption Market Share by Region
    4.2 North America
        4.2.1 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption by Country
        4.2.2 U.S.
        4.2.3 Canada
    4.3 Europe
        4.3.1 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption by Country
        4.3.2 Germany
        4.3.3 France
        4.3.4 U.K.
        4.3.5 Italy
        4.3.6 Russia
    4.4 Asia Pacific
        4.4.1 Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption by Region
        4.4.2 China
        4.4.3 Japan
        4.4.4 South Korea
        4.4.5 China Taiwan
        4.4.6 Southeast Asia
        4.4.7 India
        4.4.8 Australia
    4.5 Latin America
        4.5.1 Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption by Country
        4.5.2 Mexico
        4.5.3 Brazil
5 Segment by Type
    5.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Market Share by Type (2017-2022)
    5.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Type (2017-2022)
    5.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price by Type (2017-2022)
6 Segment by Application
    6.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Market Share by Application (2017-2022)
    6.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Application (2017-2022)
    6.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price by Application (2017-2022)
7 Key Companies Profiled
    7.1 ABITEC Corporation
        7.1.1 ABITEC Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Corporation Information
        7.1.2 ABITEC Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Portfolio
        7.1.3 ABITEC Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.1.4 ABITEC Corporation Main Business and Markets Served
        7.1.5 ABITEC Corporation Recent Developments/Updates
    7.2 AkzoNobel
        7.2.1 AkzoNobel Oral Solid Dosage Forms (OSDF) and Pharma Excipients Corporation Information
        7.2.2 AkzoNobel Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Portfolio
        7.2.3 AkzoNobel Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.2.4 AkzoNobel Main Business and Markets Served
        7.2.5 AkzoNobel Recent Developments/Updates
    7.3 Archer Daniels Midland (ADM)
        7.3.1 Archer Daniels Midland (ADM) Oral Solid Dosage Forms (OSDF) and Pharma Excipients Corporation Information
        7.3.2 Archer Daniels Midland (ADM) Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Portfolio
        7.3.3 Archer Daniels Midland (ADM) Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.3.4 Archer Daniels Midland (ADM) Main Business and Markets Served
        7.3.5 Archer Daniels Midland (ADM) Recent Developments/Updates
    7.4 BASF
        7.4.1 BASF Oral Solid Dosage Forms (OSDF) and Pharma Excipients Corporation Information
        7.4.2 BASF Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Portfolio
        7.4.3 BASF Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.4.4 BASF Main Business and Markets Served
        7.4.5 BASF Recent Developments/Updates
    7.5 DowDuPont
        7.5.1 DowDuPont Oral Solid Dosage Forms (OSDF) and Pharma Excipients Corporation Information
        7.5.2 DowDuPont Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Portfolio
        7.5.3 DowDuPont Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.5.4 DowDuPont Main Business and Markets Served
        7.5.5 DowDuPont Recent Developments/Updates
    7.6 Evonik
        7.6.1 Evonik Oral Solid Dosage Forms (OSDF) and Pharma Excipients Corporation Information
        7.6.2 Evonik Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Portfolio
        7.6.3 Evonik Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.6.4 Evonik Main Business and Markets Served
        7.6.5 Evonik Recent Developments/Updates
    7.7 J.M. Huber Corporation
        7.7.1 J.M. Huber Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Corporation Information
        7.7.2 J.M. Huber Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Portfolio
        7.7.3 J.M. Huber Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.7.4 J.M. Huber Corporation Main Business and Markets Served
        7.7.5 J.M. Huber Corporation Recent Developments/Updates
    7.8 Cargill
        7.8.1 Cargill Oral Solid Dosage Forms (OSDF) and Pharma Excipients Corporation Information
        7.8.2 Cargill Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Portfolio
        7.8.3 Cargill Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.8.4 Cargill Main Business and Markets Served
        7.7.5 Cargill Recent Developments/Updates
    7.9 Eastman Chemical Company
        7.9.1 Eastman Chemical Company Oral Solid Dosage Forms (OSDF) and Pharma Excipients Corporation Information
        7.9.2 Eastman Chemical Company Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Portfolio
        7.9.3 Eastman Chemical Company Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.9.4 Eastman Chemical Company Main Business and Markets Served
        7.9.5 Eastman Chemical Company Recent Developments/Updates
8 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturing Cost Analysis
    8.1 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Key Raw Materials Analysis
        8.1.1 Key Raw Materials
        8.1.2 Key Suppliers of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
    8.3 Manufacturing Process Analysis of Oral Solid Dosage Forms (OSDF) and Pharma Excipients
    8.4 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
    9.1 Marketing Channel
    9.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Distributors List
    9.3 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Customers
10 Market Dynamics
    10.1 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Industry Trends
    10.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Drivers
    10.3 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Challenges
    10.4 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Restraints
11 Production and Supply Forecast
    11.1 Global Forecasted Production of Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Region (2023-2028)
    11.2 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production, Revenue Forecast (2023-2028)
    11.3 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production, Revenue Forecast (2023-2028)
    11.4 China Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production, Revenue Forecast (2023-2028)
    11.5 Japan Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production, Revenue Forecast (2023-2028)
12 Consumption and Demand Forecast
    12.1 Global Forecasted Demand Analysis of Oral Solid Dosage Forms (OSDF) and Pharma Excipients
    12.2 North America Forecasted Consumption of Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Country
    12.3 Europe Market Forecasted Consumption of Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Country
    12.4 Asia Pacific Market Forecasted Consumption of Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Region
    12.5 Latin America Forecasted Consumption of Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Country
13 Forecast by Type and by Application (2023-2028)
    13.1 Global Production, Revenue and Price Forecast by Type (2023-2028)
        13.1.1 Global Forecasted Production of Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Type (2023-2028)
        13.1.2 Global Forecasted Revenue of Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Type (2023-2028)
        13.1.3 Global Forecasted Price of Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Type (2023-2028)
    13.2 Global Forecasted Consumption of Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Application (2023-2028)
        13.2.1 Global Forecasted Production of Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Application (2023-2028)
        13.2.2 Global Forecasted Revenue of Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Application (2023-2028)
        13.2.3 Global Forecasted Price of Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Application (2023-2028)
14 Research Finding and Conclusion
15 Methodology and Data Source
    15.1 Methodology/Research Approach
        15.1.1 Research Programs/Design
        15.1.2 Market Size Estimation
        15.1.3 Market Breakdown and Data Triangulation
    15.2 Data Source
        15.2.1 Secondary Sources
        15.2.2 Primary Sources
    15.3 Author List
    15.4 Disclaimer

List of Tables
    Table 1. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Type (K Units) & (US$ Million) (2022 VS 2028)
    Table 2. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Application (K Units) & (US$ Million) (2022 VS 2028)
    Table 3. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size Comparison by Region: 2017 VS 2021 VS 2028
    Table 4. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity by Manufacturers (2017-2022) & (K Units)
    Table 5. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production (K Units) by Manufacturers (2017-2022)
    Table 6. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Market Share by Manufacturers (2017-2022)
    Table 7. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 8. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Share by Manufacturers (2017-2022)
    Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Solid Dosage Forms (OSDF) and Pharma Excipients as of 2021)
    Table 10. Global Market Oral Solid Dosage Forms (OSDF) and Pharma Excipients Average Price (USD/Unit) of Key Manufacturers (2017-2022)
    Table 11. Manufacturers Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Sites and Area Served
    Table 12. Manufacturers Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Types
    Table 13. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Mergers & Acquisitions, Expansion
    Table 15. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity (K Units) by Region (2017-2022)
    Table 16. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production (K Units) by Region (2017-2022)
    Table 17. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (US$ Million) by Region (2017-2022)
    Table 18. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Region (2017-2022)
    Table 19. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 20. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 21. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 22. China Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 23. Japan Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 24. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption Market by Region (2017-2022) & (K Units)
    Table 25. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption Market Share by Region (2017-2022)
    Table 26. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption by Country (2017-2022) & (K Units)
    Table 27. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption by Country (2017-2022) & (K Units)
    Table 28. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption by Region (2017-2022) & (K Units)
    Table 29. Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption by Country (2017-2022) & (K Units)
    Table 30. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production (K Units) by Type (2017-2022)
    Table 31. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Market Share by Type (2017-2022)
    Table 32. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (US$ Million) by Type (2017-2022)
    Table 33. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Share by Type (2017-2022)
    Table 34. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price (USD/Unit) by Type (2017-2022)
    Table 35. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production by Application (2017-2022) & (K Units)
    Table 36. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Market Share by Application (2017-2022)
    Table 37. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (US$ Million) by Application (2017-2022)
    Table 38. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Share by Application (2017-2022)
    Table 39. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price (USD/Unit) by Application (2017-2022)
    Table 40. ABITEC Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Corporation Information
    Table 41. ABITEC Corporation Specification and Application
    Table 42. ABITEC Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 43. ABITEC Corporation Main Business and Markets Served
    Table 44. ABITEC Corporation Recent Developments/Updates
    Table 45. AkzoNobel Oral Solid Dosage Forms (OSDF) and Pharma Excipients Corporation Information
    Table 46. AkzoNobel Specification and Application
    Table 47. AkzoNobel Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 48. AkzoNobel Main Business and Markets Served
    Table 49. AkzoNobel Recent Developments/Updates
    Table 50. Archer Daniels Midland (ADM) Oral Solid Dosage Forms (OSDF) and Pharma Excipients Corporation Information
    Table 51. Archer Daniels Midland (ADM) Specification and Application
    Table 52. Archer Daniels Midland (ADM) Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 53. Archer Daniels Midland (ADM) Main Business and Markets Served
    Table 54. Archer Daniels Midland (ADM) Recent Developments/Updates
    Table 55. BASF Oral Solid Dosage Forms (OSDF) and Pharma Excipients Corporation Information
    Table 56. BASF Specification and Application
    Table 57. BASF Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 58. BASF Main Business and Markets Served
    Table 59. BASF Recent Developments/Updates
    Table 60. DowDuPont Oral Solid Dosage Forms (OSDF) and Pharma Excipients Corporation Information
    Table 61. DowDuPont Specification and Application
    Table 62. DowDuPont Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 63. DowDuPont Main Business and Markets Served
    Table 64. DowDuPont Recent Developments/Updates
    Table 65. Evonik Oral Solid Dosage Forms (OSDF) and Pharma Excipients Corporation Information
    Table 66. Evonik Specification and Application
    Table 67. Evonik Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 68. Evonik Main Business and Markets Served
    Table 69. Evonik Recent Developments/Updates
    Table 70. J.M. Huber Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Corporation Information
    Table 71. J.M. Huber Corporation Specification and Application
    Table 72. J.M. Huber Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 73. J.M. Huber Corporation Main Business and Markets Served
    Table 74. J.M. Huber Corporation Recent Developments/Updates
    Table 75. Cargill Oral Solid Dosage Forms (OSDF) and Pharma Excipients Corporation Information
    Table 76. Cargill Specification and Application
    Table 77. Cargill Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 78. Cargill Main Business and Markets Served
    Table 79. Cargill Recent Developments/Updates
    Table 80. Eastman Chemical Company Oral Solid Dosage Forms (OSDF) and Pharma Excipients Corporation Information
    Table 81. Eastman Chemical Company Specification and Application
    Table 82. Eastman Chemical Company Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 83. Eastman Chemical Company Main Business and Markets Served
    Table 84. Eastman Chemical Company Recent Developments/Updates
    Table 85. Production Base and Market Concentration Rate of Raw Material
    Table 86. Key Suppliers of Raw Materials
    Table 87. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Distributors List
    Table 88. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Customers List
    Table 89. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Trends
    Table 90. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Drivers
    Table 91. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Challenges
    Table 92. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Restraints
    Table 93. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production (K Units) Forecast by Region (2023-2028)
    Table 94. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption Forecast by Country (2023-2028) & (K Units)
    Table 95. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption Forecast by Country (2023-2028) & (K Units)
    Table 96. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption Forecast by Region (2023-2028) & (K Units)
    Table 97. Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption Forecast by Country (2023-2028) & (K Units)
    Table 98. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Forecast by Type (2023-2028) & (K Units)
    Table 99. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 100. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 101. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Forecast by Application (2023-2028) & (K Units)
    Table 102. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 103. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 104. Research Programs/Design for This Report
    Table 105. Key Data Information from Secondary Sources
    Table 106. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Oral Solid Dosage Forms (OSDF) and Pharma Excipients
    Figure 2. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Share by Type: 2022 VS 2028
    Figure 3. Glycerin Product Picture
    Figure 4. Propylene Glycol Product Picture
    Figure 5. Sorbitol Product Picture
    Figure 6. Mannitol Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Share by Application: 2022 VS 2028
    Figure 9. Industrial Application
    Figure 10. Non-industrial Application
    Figure 11. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (US$ Million) (2017-2028)
    Figure 13. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity (K Units) & (2017-2028)
    Figure 14. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production (K Units) & (2017-2028)
    Figure 15. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (US$ Million) and Growth Rate (2017-2028)
    Figure 16. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (US$ Million) and Growth Rate (2017-2028)
    Figure 17. China Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (US$ Million) and Growth Rate (2017-2028)
    Figure 18. Japan Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (US$ Million) and Growth Rate (2017-2028)
    Figure 19. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Share by Manufacturers in 2021
    Figure 20. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Share by Manufacturers in 2021
    Figure 21. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 22. Global Market Oral Solid Dosage Forms (OSDF) and Pharma Excipients Average Price (USD/Unit) of Key Manufacturers in 2021
    Figure 23. The Global 5 and 10 Largest Players: Market Share by Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue in 2021
    Figure 24. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Market Share by Region (2017-2022)
    Figure 25. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production (K Units) Growth Rate (2017-2022)
    Figure 26. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production (K Units) Growth Rate (2017-2022)
    Figure 27. China Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production (K Units) Growth Rate (2017-2022)
    Figure 28. Japan Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production (K Units) Growth Rate (2017-2022)
    Figure 29. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption Market Share by Region (2017-2022)
    Figure 30. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption and Growth Rate (2017-2022) & (K Units)
    Figure 31. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption Market Share by Country in 2021
    Figure 32. Canada Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption Growth Rate (2017-2022) & (K Units)
    Figure 33. U.S. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption Growth Rate (2017-2022) & (K Units)
    Figure 34. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption Growth Rate (2017-2022) & (K Units)
    Figure 35. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption Market Share by Country in 2021
    Figure 36. Germany Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption and Growth Rate (2017-2022) & (K Units)
    Figure 37. France Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption and Growth Rate (2017-2022) & (K Units)
    Figure 38. U.K. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption and Growth Rate (2017-2022) & (K Units)
    Figure 39. Italy Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption and Growth Rate (2017-2022) & (K Units)
    Figure 40. Russia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption and Growth Rate (2017-2022) & (K Units)
    Figure 41. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption and Growth Rate (2017-2022) & (K Units)
    Figure 42. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption Market Share by Regions in 2021
    Figure 43. China Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption and Growth Rate (2017-2022) & (K Units)
    Figure 44. Japan Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption and Growth Rate (2017-2022) & (K Units)
    Figure 45. South Korea Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption and Growth Rate (2017-2022) & (K Units)
    Figure 46. China Taiwan Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption and Growth Rate (2017-2022) & (K Units)
    Figure 47. Southeast Asia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption and Growth Rate (2017-2022) & (K Units)
    Figure 48. India Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption and Growth Rate (2017-2022) & (K Units)
    Figure 49. Australia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption and Growth Rate (2017-2022) & (K Units)
    Figure 50. Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption and Growth Rate (2017-2022) & (K Units)
    Figure 51. Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption Market Share by Country in 2021
    Figure 52. Mexico Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption and Growth Rate (2017-2022) & (K Units)
    Figure 53. Brazil Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption and Growth Rate (2017-2022) & (K Units)
    Figure 54. Production Market Share of Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Type (2017-2022)
    Figure 55. Production Market Share of Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Type in 2021
    Figure 56. Revenue Share of Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Type (2017-2022)
    Figure 57. Revenue Market Share of Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Type in 2021
    Figure 58. Production Market Share of Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Application (2017-2022)
    Figure 59. Production Market Share of Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Application in 2021
    Figure 60. Revenue Share of Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Application (2017-2022)
    Figure 61. Revenue Market Share of Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Application in 2021
    Figure 62. Manufacturing Cost Structure of Oral Solid Dosage Forms (OSDF) and Pharma Excipients
    Figure 63. Manufacturing Process Analysis of Oral Solid Dosage Forms (OSDF) and Pharma Excipients
    Figure 64. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Industrial Chain Analysis
    Figure 65. Channels of Distribution
    Figure 66. Distributors Profiles
    Figure 67. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Market Share Forecast by Region (2023-2028)
    Figure 68. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production (K Units) Growth Rate Forecast (2023-2028)
    Figure 69. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production (K Units) Growth Rate Forecast (2023-2028)
    Figure 70. China Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production (K Units) Growth Rate Forecast (2023-2028)
    Figure 71. Japan Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production (K Units) Growth Rate Forecast (2023-2028)
    Figure 72. Global Forecasted Demand Analysis of Oral Solid Dosage Forms (OSDF) and Pharma Excipients (2017-2028) & (K Units)
    Figure 73. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Market Share Forecast by Type (2023-2028)
    Figure 74. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share Forecast by Type (2023-2028)
    Figure 75. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Market Share Forecast by Application (2023-2028)
    Figure 76. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share Forecast by Application (2023-2028)
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
ABITEC Corporation
AkzoNobel
Archer Daniels Midland (ADM)
BASF
DowDuPont
Evonik
J.M. Huber Corporation
Cargill
Eastman Chemical Company
Frequently Asked Questions
Oral Solid Dosage Forms (OSDF) and Pharma Excipients report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Oral Solid Dosage Forms (OSDF) and Pharma Excipients report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Oral Solid Dosage Forms (OSDF) and Pharma Excipients report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports